Advertisement
Screener

Bionano Genomics, Inc. (BNGO) EBITDA

Bionano Genomics, Inc. (BNGO) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$4.92M*; Operating income -$7.22M; Depreciation and amortization $2.30M*.
  • 2026-03-31: Basis Reported; EBITDA -$5.59M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$6.2M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$6.16M*; Operating income -$8.54M; Depreciation and amortization $2.38M*.

Complete source-backed ebitda history.

Available history
2017-09-30 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$4.92M*-$7.22M$2.30M*$8.17M-60.24%*(m)-$4.67M*$3.86M$2.99M$8.54M$7.00K
2026-03-31Reported-$5.59M(m)(m)(m)-83.55%(m)-$5.72M$3.44M$3.14M$8.01M$10.00K
2025-12-31Reported-$6.2M(m)(m)(m)-77.97%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$6.16M*-$8.54M$2.38M*$7.37M-83.64%*(m)-$5.92M*$4.00M$2.84M$9.06M$14.00K
2025-06-30Reported-$5.42M*-$7.80M$2.38M*$6.73M-80.50%*(m)-$3.49M*$3.26M$2.93M$8.35M$10.00K
2025-03-31Reported-$6.03M(m)(m)(m)-93.40%(m)-$2.76M$3.52M$2.37M$9.03M$7.00K
2024-12-31Reported-$9.54M(m)(m)(m)-116.91%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$38.27M*-$43.90M$5.63M*$6.07M-630.20%*(m)-$13.31M*$14.52M$4.72M$9.46M$24.00K
2024-06-30Reported-$14.03M*-$17.02M$2.99M*$7.77M-180.54%*(m)-$20.98M*$5.19M$6.83M$11.56M$26.00K
2024-03-31Reported-$28.12M(m)(m)(m)-320.63%(m)-$28.13M$5.95M$9.78M$19.09M-$18.00K
2023-12-31Reported-$21.36M(m)(m)(m)-199.21%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$109.59M*-$113.21M$3.63M*$9.32M-1176.08%*(m)-$26.29M*$6.57M$13.79M$24.90M$39.00K
2023-06-30Reported-$35.94M*-$39.24M$3.30M*$8.66M-414.93%*(m)-$36.70M*$6.35M$14.61M$26.94M$33.00K
2023-03-31Reported-$34.65M(m)(m)(m)-467.34%(m)-$32.41M$5.34M$13.94M$25.98M$26.00K
2022-12-31Reported-$34.76M(m)(m)(m)-423.14%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$29.77M*-$32.15M$2.38M*$7.22M-412.26%*(m)-$29.47M*$5.41M$12.74M$21.22M$28.00K
2022-06-30Reported-$29.81M*-$32.08M$2.27M*$6.67M-446.99%*(m)-$28.33M*$5.20M$11.77M$21.78M$41.00K
2022-03-31Reported-$27.73M(m)(m)(m)-486.89%(m)-$32.49M$4.83M$10.53M$20.28M$9.00K
2021-12-31Reported-$26.92M(m)(m)(m)-427.20%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$20.15M*-$20.68M$526.00K*$4.66M-432.91%*$268.00K*-$19.98M*$3.50M$6.50M$15.33M$35.00K
2021-06-30Reported-$15.96M*-$16.48M$516.00K*$3.86M-413.90%*$52.00K*-$12.42M*$2.42M$4.09M$13.83M$9.00K
2021-03-31Reported-$10.72M(m)(m)(m)-338.23%$24.00K-$13.90M$2.13M$2.68M$9.53M$6.00K
2020-12-31Reported-$10.56M(m)(m)(m)-264.56%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$9.91M*-$10.23M$318.00K*$2.20M-451.23%*$0.00*-$10.96M*$1.46M$2.30M$8.66M$30.00K
2020-06-30Reported-$7.14M*-$7.43M$295.00K*$1.18M-604.06%*$0.00*-$7.22M*$603.00K$2.40M$5.61M$5.00K
2020-03-31Reported-$9.47M(m)(m)(m)-833.27%$0.00-$8.03M$856.00K$2.67M$7.37M$5.00K
2019-12-31Reported-$6.85M(m)(m)(m)-245.49%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$5.41M(m)(m)(m)-163.20%$8.00K*-$7.28M*$2.38M$2.17M$4.45M$4.00K
2019-06-30Reported-$6.58M(m)(m)(m)-302.39%$30.00K*-$6.32M*$1.55M$2.41M$5.06M$5.00K
2019-03-31Reported-$5.92M(m)(m)(m)-319.21%$0.00-$6.55M$1.15M$2.10M$4.79M$5.00K
2018-12-31Reported-$5.95M(m)(m)(m)-148.19%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$5.58M(m)(m)(m)-197.18%$130.48K*-$6.10M*$3.07M$2.51M$3.22M-$2.98K
2018-06-30Reported-$3.63M(m)(m)(m)-106.94%$177.57K*-$2.97M*$1.81M$2.10M$3.49M$5.51K
2018-03-31Reported-$3.94M(m)(m)(m)-223.02%$11.83K-$6.79M$841.45K$2.37M$2.90M$3.78K
2017-12-31Reported-$4.7M(m)(m)(m)-165.20%(m)(m)(m)(m)(m)(m)
2017-09-30Reported-$4.79M(m)(m)(m)-174.65%(m)(m)$1.69M$2.97M$3.12M-$4.74K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$23.81M(m)(m)(m)-83.53%(m)-$16.34M$15.32M$11.37M$35.15M$67.00K
2024-12-31Reported-$89.96M(m)(m)(m)-292.31%(m)-$68.92M$30.40M$24.80M$51.85M$33.00K
2023-12-31Reported-$201.54M(m)(m)(m)-558.03%(m)-$125.18M$26.55M$54.03M$92.76M$62.00K
2022-12-31Reported-$122.08M(m)(m)(m)-439.09%(m)-$124.82M$21.86M$49.05M$88.60M$1.88M
2021-12-31Reported-$73.75M(m)(m)(m)-410.16%(m)-$71.93M$14.11M$22.48M$58.49M-$5.72M
2020-12-31Reported-$37.07M(m)(m)(m)-435.99%$0.00-$38.31M$5.73M$10.26M$31.07M$29.00K
2019-12-31Reported-$24.75M(m)(m)(m)-244.31%$61.06K-$29.53M$6.77M$9.08M$20.16M$21.05K
2018-12-31Reported-$19.09M(m)(m)(m)-159.11%$331.72K-$19.94M$8.71M$9.48M$14.22M$15.51K
2017-12-31Reported-$21.71M(m)(m)(m)-228.46%$1.02M-$20.82M$6.03M$12.01M$14.08M$18.55K

Similar stocks

Stock NameCountryMarket CapPE Ratio
ASTROTECH Corp (ASTC)United States$0.013B
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Precipio, Inc. (PRPO)United States$0.043B-36.70
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15